Cited by 149Pharmacogenetics and Drug MetabolismToxic Organic Pollutants ImpactPeroxisome Proliferator-Activated Receptors

The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.

Identification of a Novel Dioxin-Inducible Cytochrome P450

Rivera, Steven P., Saarikoski, Sirkku T., Hankinson, Oliver·2002·Molecular Pharmacology

DOI 10.1016/s0026-895x(24)12856-8

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0026-895x(24)12856-8

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · cited 1×
“Dioxin is the most carcinogenic substance evaluated (Hankinson, 1995).”
Self-citation
INDUCTION OF CYTOCHROME P4501A1
Whitlock, J. P. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.103 · Cited by 1,136
Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression.
Savas, Ü., Bhattacharyya, K. K., Christou, M., Alexander, D. L., & Jefcoate, C. R. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36551-1 · Cited by 206
Induction of mRNA specific for cytochrome P1-450 in wild type and variant mouse hepatoma cells.
Israel, D. I., & Whitlock, J. P. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44469-3 · Cited by 115
Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization
Dey, A., Jones, J. E., & Nebert, D. W. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00110-0 · Cited by 113
Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)
Rylander‐Rudqvist, T., Neve, E. P. A., Ingelman‐Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4390 · Cited by 106
Superinduction of cytochrome P1-450 gene transcription by inhibition of protein synthesis in wild type and variant mouse hepatoma cells.
Israel, D. I., Estolano, M. G., Galeazzi, D. R., & Whitlock, J. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89072-x · Cited by 103
A Mutation in the Aryl Hydrocarbon Receptor (AHR) in a Cultured Mammalian Cell Line Identifies a Novel Region of AHR That Affects DNA Binding
Sun, W., Zhang, J., & Hankinson, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31845 · Cited by 63
Self-citation
Differential Time–Course and Dose–Response Relationships of TCDD-Induced CYP1B1, CYP1A1, and CYP1A2 Proteins in Rats
Santostefano, M. J., Ross, D. G., Savas, Ü., Jefcoate, C. R. E., & Birnbaum, L. S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6389 · Cited by 56
A genetic analysis of processes regulating cytochrome P4501A1 expression
Hankinson, O. (1994) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(94)90015-9 · Cited by 24
Self-citation

Show all 12 references

Sorted by citations

Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts
Ding, X., & Kaminsky, L. S. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140251 · Cited by 819
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology
Mandal, P. K. (2005) · Journal of Comparative Physiology B · doi:10.1007/s00360-005-0483-3 · Cited by 613
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 571
Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., & Mann, M. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800258-mcp200 · Cited by 561
“Two of them (CYP1A1 and CYP2S1) are known to be regulated by the aryl hydrogen receptor (25, 26 ).”
Background
Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
Ingelman‐Sundberg, M. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0819-z · Cited by 355
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P. H., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 339
Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung
Hukkanen, J., Pelkonen, O., Hakkola, J., & Raunio, H. (2002) · Critical Reviews in Toxicology · doi:10.1080/20024091064273 · Cited by 319
Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation
Uno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., & Nebert, D. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1225 · Cited by 316
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann‐Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 309
Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues
Choudhary, D., Jansson, I., Schenkman, J. B., Sarfarazi, M., & Stoilov, I. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00174-7 · Cited by 251
Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate
Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., & Nebert, D. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.021501 · Cited by 227
Human Cytochrome P450 Enzymes
Guengerich, F. P. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_10 · Cited by 226
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells
Dauchy, S., Miller, F., Couraud, P., Weaver, R. J., Weksler, B. B., Romero, I. A., Scherrmann, J., de Waziers, I., & Declèves, X. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.001 · Cited by 207
Markers of genetic susceptibility in human environmental hygiene and toxicology: The role of selected CYP, NAT and GST genes
Thier, R., Brüning, T., Roos, P. H., Rihs, H., Golka, K., Ko, Y. D., & Bolt, H. M. (2003) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00209 · Cited by 195
Ah receptor signals cross-talk with multiple developmental pathways
Puga, A., Tomlinson, C. R., & Xia, Y. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.043 · Cited by 178
A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
Lee, J., Beers, J. L., Geffert, R. M., & Jackson, K. D. (2024) · Biomolecules · doi:10.3390/biom14010099 · Cited by 184
The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Cardiovascular Diseases
Korashy, H. M., & El‐Kadi, A. O. S. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600632063 · Cited by 175
Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis
Kumarakulasingham, M., Rooney, P. H., Dundas, S. R., Telfer, C., Melvin, W. T., Curran, S., & Murray, G. I. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1848 · Cited by 171
Polymorphisms in the human AH receptor
Harper, P. A., Wong, J. M. Y., Lam, M. S. M., & Okey, A. B. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00071-6 · Cited by 168
Human Cytochrome P450 Enzymes
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 159
Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases
Smith, G. C., Wolf, C. R., Deeni, Y., Dawe, R. S., Evans, A. T., Comrie, M., Ferguson, J., & Ibbotson, S. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13081-4 · Cited by 153
Role of the aryl hydrocarbon receptor in drug metabolism
Ramadoss, P., Marcus, C. B., & Perdew, G. H. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.9 · Cited by 147
Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical
Sinz, M., Wallace, G., & Sahi, J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9037-4 · Cited by 143
The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease
Fleming, I. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007781 · Cited by 140
Function of human cytochrome P450s: Characterization of the orphans
Guengerich, F. P., Wu, Z., & Bartleson, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.079 · Cited by 133
The human genome project and novel aspects of cytochrome 450 research
Ingelman‐Sundberg, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.030 · Cited by 125
Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers
Thum, T., Erpenbeck, V. J., Moeller, J., Hohlfeld, J. M., Krug, N., & Borlak, J. T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8861 · Cited by 123
Timing is everything: Consequences of transient and sustained AhR activity
Mitchell, K. A., & Elferink, C. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.028 · Cited by 120
Cyp1a1(−/−) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria
Uno, S. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.014 · Cited by 116
CYP2S1: A short review
Saarikoski, S. T., Rivera, S. P., Hankinson, O., & Husgafvel‐Pursiainen, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.027 · Cited by 109
Self-citation
Distinct Populations of Hepatic Stellate Cells in the Mouse Liver Have Different Capacities for Retinoid and Lipid Storage
D’Ambrosio, D. N., Walewski, J. L., Clugston, R. D., Berk, P. D., Rippe, R. A., & Blaner, W. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024993 · Cited by 112
Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology
Guengerich, F. P., & Cheng, Q. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003525 · Cited by 103
Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective
Swanson, H. I. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.08.006 · Cited by 107
Cytochrome P450 1 Genes in Early Deuterostomes (Tunicates and Sea Urchins) and Vertebrates (Chicken and Frog): Origin and Diversification of the CYP1 Gene Family
Goldstone, J. V., Goldstone, H. M. H., Morrison, A. M., Tarrant, A. M., Kern, S. E., Woodin, B. R., & Stegeman, J. J. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm200 · Cited by 104
Novel extrahepatic cytochrome P450s
Karlgren, M., MIURA, S., & Ingelman‐Sundberg, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.022 · Cited by 101
Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1
Wu, Z., Sohl, C. D., Shimada, T., & Guengerich, F. P. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023648 · Cited by 99
Regulation of CYP1A1 by heavy metals and consequences for drug metabolism
Anwar‐Mohamed, A., Elbekai, R. H., & El‐Kadi, A. O. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902918302 · Cited by 93
tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand
Gharavi, N., & El-Kadi, A. O. S. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002253 · Cited by 87
The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+
Elbekai, R. H., & El‐Kadi, A. O. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.012 · Cited by 86
Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
Levine, A., Chen, L., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.461 · Cited by 84
Extrahepatic metabolism at the body's internal–external interfaces
Gundert‐Remy, U., Bernauer, U., Blömeke, B., Döring, B., Fabian, E. J., Goebel, C., Hessel‐Pras, S., Jäckh, C., Lampen, A., Oesch, F., et al. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.900565 · Cited by 88
The aryl hydrocarbon receptor and light
Rannug, A., & Fritsche, E. (2006) · Biological Chemistry · doi:10.1515/bc.2006.143 · Cited by 80
Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models
Oesch, F., Fabian, E. J., & Landsiedel, R. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02602-7 · Cited by 79
CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody
Zhu, L.-R., Thomas, P. E., Lǚ, G., Reuhl, K. R., Yang, G., Wang, L., Wang, S.-L., Yang, C. S., He, X., & Hong, J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011049 · Cited by 74
Epidermal CYP2 family cytochromes P450
Du, L., Hoffman, S. M. G., & Keeney, D. S. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.09.020 · Cited by 74
A Novel Promoter Element Containing Multiple Overlapping Xenobiotic and Hypoxia Response Elements Mediates Induction of Cytochrome P4502S1 by Both Dioxin and Hypoxia
Rivera, S. P., Wang, F., Saarikoski, S. T., Taylor, R. T., Chapman, B., Zhang, R., & Hankinson, O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609617200 · Cited by 71
Self-citation
Human CYP2S1 Metabolizes Cyclooxygenase- and Lipoxygenase-Derived Eicosanoids
Bui, P. H., Imaizumi, S., Beedanagari, S. R., Reddy, S. T., & Hankinson, O. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035121 · Cited by 68
Self-citation
Characterization of Orphan Human Cytochromes P450
Stark, K., & Guengerich, F. P. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701467708 · Cited by 68
Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium
Elbekai, R. H., & El‐Kadi, A. O. S. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.05.009 · Cited by 67
Skin Retinoid Concentrations Are Modulated by CYP26AI Expression Restricted to Basal Keratinocytes in Normal Human Skin and Differentiated 3D Skin Models
Heise, R., Mey, J., Neis, M. M., Marquardt, Y., Joussen, S., Ott, H., Wiederholt, T., Kurschat, P., Megahed, M., Bickers, D. R., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700432 · Cited by 65
Localization of Cytochrome P450 CYP2S1 Expression in Human Tissues by In Situ Hybridization and Immunohistochemistry
Saarikoski, S. T., Wikman, H., Smith, G. C., Wolff, C. H. J., & Husgafvel‐Pursiainen, K. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4c6576.2005 · Cited by 65
Self-citation
Mechanisms of TCDD-induced abnormalities and embryo lethality in white leghorn chickens
Blankenship, A. L., Hilscherová, K., Nie, M., Coady, K. K., Villalobos, S. A., Kannan, K., Powell, D. C., Bursian, S. J., & Giesy, J. P. (2003) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00166-2 · Cited by 64
Aryl hydrocarbon receptor‐dependent induction of apoptosis by 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in cerebellar granule cells from mouse
Sánchez-Martín, F. J., Fernández‐Salguero, P. M., & Merino, J. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07291.x · Cited by 58
Regulation of the Cyp2a5 Gene Involves an Aryl Hydrocarbon Receptor-Dependent Pathway
Arpiainen, S., Raffalli‐Mathieu, F., Lang, M. A., Pelkonen, O., & Hakkola, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008078 · Cited by 56
Roles of Coactivator Proteins in Dioxin Induction of CYP1A1 and CYP1B1 in Human Breast Cancer Cells
Taylor, R. T., Wang, F., Hsu, E. L., & Hankinson, O. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn217 · Cited by 54
Self-citation
Overexpression of latent transforming growth factor-β binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
Santiago‐Josefat, B., Mulero‐Navarro, S., Dallas, S. L., & Fernández‐Salguero, P. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.00932 · Cited by 53
Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques
Frömel, T., Kohlstedt, K., Popp, R., Yin, X., Awwad, K., Barbosa‐Sicard, E., Thomas, A. C., Lieberz, R., Mayr, M., & Fleming, I. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0319-8 · Cited by 50
Induction and superinduction of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly(ADP-ribose) polymerase: Role of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator transcription activation domains and a labile transcription repressor
Ma, Q. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00339-9 · Cited by 50
Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol
Bui, P. H., Hsu, E. L., & Hankinson, O. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.057760 · Cited by 49
Self-citation
Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli
Bui, P. H., & Hankinson, O. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.057752 · Cited by 49
Self-citation
Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy
Singh, R., Avadhesh, A., Sharma, G., Dholariya, S. J., Shah, R., Goyal, B., & Gupta, S. C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0116 · Cited by 46
High-Throughput Screening for Drug Discovery
Saxena, S. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.91075 · Cited by 46
Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology
Guo, S., Simsa, P., Kyama, C. M., Mihalyi, A., Fulop, V., Othman, E.-E. R., & D’Hooghe, T. M. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap075 · Cited by 45
Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding Motif
Carr, B., Wan, J., Hines, R. N., & Yost, G. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300319200 · Cited by 45
Differential modulation of aryl hydrocarbon receptor regulated enzymes by arsenite in the kidney, lung, and heart of C57BL/6 mice
Anwar‐Mohamed, A., Abdelhamid, G., Amara, I. E. A., & El‐Kadi, A. O. S. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0855-x · Cited by 39
Reduction of Aromatic and Heterocyclic AromaticN-Hydroxylamines by Human Cytochrome P450 2S1
Wang, K., & Guengerich, F. P. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400139p · Cited by 39
HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
Wang, S., He, X., & Hong, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002923 · Cited by 37
Benzo[a]pyrene impedes self-renewal and differentiation of mesenchymal stem cells and influences fracture healing
Zhou, Y., Jiang, R., An, L., Wang, H., Cheng, S., Shi, Q., & Weng, Y. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.02.152 · Cited by 37
Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics
Al‐Majdoub, Z. M., Couto, N. A. S., Achour, B., Harwood, M. D., Carlson, G., Warhurst, G., Barber, J., & Rostami‐Hodjegan, A. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2097 · Cited by 36
Detection of electrophoretically separated cytochromes P450 by element-labelled monoclonal antibodies via laser ablation inductively coupled plasma mass spectrometry
Roos, P. H., Venkatachalam, A., Manz, A., Waentig, L., Koehler, C. U., & Jakubowski, N. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2242-2 · Cited by 35
Recruitment of CREB1 and Histone Deacetylase 2 (HDAC2) to the Mouse Ltbp-1 Promoter Regulates its Constitutive Expression in a Dioxin Receptor-dependent Manner
Gómez-Durán, Á., Ballestar, E., Carvajal-González, J. M., Marlowe, J. L., Puga, A., Esteller, M., & Fernández‐Salguero, P. M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.056 · Cited by 34
Theophylline pharmacokinetics: comparison of Cyp1a1(−/−) and Cyp1a2(−/−) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice
Derkenne, S., Curran, C. P., Shertzer, H. G., Dalton, T. P., Dragin, N., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000167326.00411.50 · Cited by 34
Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms
Anwar‐Mohamed, A., Elshenawy, O. H., Soshilov, A. A., Denison, M. S., Le, X. C., Klotz, L., & El‐Kadi, A. O. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.810 · Cited by 33
Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population
Saito, S., Iida, A., Sekine, A., Kawauchi, S., Higuchi, S., Ogawa, C., & Nakamura, Y. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0021-7 · Cited by 30
Cytochrome P450 2S1 is Reduced by NADPH-Cytochrome P450 Reductase
Xiao, Y., Shinkyo, R., & Guengerich, F. P. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039321 · Cited by 29
Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers
Dörrenhaus, A., Müller, T., & Roos, P. H. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0134-9 · Cited by 28
Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells
Thomas, R. D., Green, M. R., Wilson, C., Weckle, A. L., Duanmu, Z., Kocarek, T. A., & Runge‐Morris, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.01.007 · Cited by 28
Characterization of a Human Keratinocyte HaCaT Cell Line Model to Study the Regulation of CYP2S1
McNeilly, A. D., Woods, J. A., Ibbotson, S. H., Wolf, C. R., & Smith, G. C. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042085 · Cited by 27
Down‐regulation of aryl hydrocarbon receptor–regulated genes by tumor necrosis factor‐α and lipopolysaccharide in murine hepatoma hepa 1c1c7 cells
Gharavi, N., & El‐Kadi, A. O. S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20267 · Cited by 27
Cytochrome P450 2S1 Depletion Enhances Cell Proliferation and Migration in Bronchial Epithelial Cells, in Part, through Modulation of Prostaglandin E2 Synthesis
Madanayake, T. W., Fidler, T. P., Fresquez, T., Bajaj, N., & Rowland, A. M. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046466 · Cited by 23
The Toll-like receptor agonist imiquimod is metabolized by aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in human keratinocytes and mouse liver
Mescher, M., Tigges, J., Rolfes, K. M., Shen, A. L., Yee, J. S., Vogeley, C., Krutmann, J., Bradfield, C. A., Lang, D. H., & Haarmann‐Stemmann, T. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02488-5 · Cited by 23
Evolution of the CYP2ABFGST gene cluster in rat, and a fine-scale comparison among rodent and primate species
Hu, S., Wang, H., Knisely, A. A., Reddy, S., Kovacevic, D., Liu, Z. Y., & Hoffman, S. M. G. (2007) · Genetica · doi:10.1007/s10709-007-9206-x · Cited by 22
AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells
Roblin, S., Okey, A. B., & Harper, P. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.016 · Cited by 22
The dioxin/aryl hydrocarbon receptor mediates downregulation of osteopontin gene expression in a mouse model of gastric tumourigenesis
Kuznetsov, N., Andersson, P., Gradin, K., von Stein, P., Dieckmann, A., Pettersson, S., Hanberg, A., & Poellinger, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208529 · Cited by 23
Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: Its regulation by aryl hydrocarbon receptor agonists
Deb, S., & Bandiera, S. M. (2009) · Toxicology · doi:10.1016/j.tox.2009.10.025 · Cited by 21
CYP2S1 is a synthetic lethal target in BRAFV600E-driven thyroid cancers
Li, Y., Su, X., Feng, C., Liu, S., Guan, H., Sun, Y., He, N., Ji, M., & Hou, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00231-6 · Cited by 21
CYP2S1 depletion enhances colorectal cell proliferation is associated with PGE2-mediated activation of β-catenin signaling
Yang, C., Li, C.-Y., Li, M., Tong, X., Hu, X., Yang, X., Yan, X., He, L., & Wan, C. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.12.008 · Cited by 21
MOLECULAR MECHANISMS REGULATING HUMAN CYP4B1 LUNG-SELECTIVE EXPRESSION
Poch, M. T., Cutler, N. S., Yost, G. S., & Hines, R. N. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004523 · Cited by 21
Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As3+, Cd2+ and Cr6+
Elbekai, R. H., Duke, J., & El‐Kadi, A. O. S. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.029 · Cited by 20
Role of Nitric Oxide in Downregulation of Cytochrome P450 1a1 and NADPH: Quinone Oxidoreductase 1 by Tumor Necrosis Factor‐α and Lipopolysaccharide
Gharavi, N., & El‐Kadi, A. O. S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20910 · Cited by 19
Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population
Saarikoski, S. T., Suitiala, T., Holmila, R. J., Impivaara, O., Järvisalo, J. O., Hirvonen, A., & Husgafvel‐Pursiainen, K. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.007 · Cited by 18
Self-citation
The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons
Riddick, D. S., Lee, C., Bhathena, A., & Timsit, Y. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-003 · Cited by 17
Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications
Elbekai, R. H., & El‐Kadi, A. O. S. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.03.010 · Cited by 16
Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL/6 mice
Anwar‐Mohamed, A., Abdelhamid, G., Amara, I. E. A., & El‐Kadi, A. O. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.012 · Cited by 16
Occupational exposure to polycyclic aromatic hydrocarbons suppresses constitutive expression of CYP1B1 on the transcript level in human leukocytes
Lemm, F., Wilhelm, M., & Roos, P. H. (2004) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00298 · Cited by 16
Identification of novel dioxin-responsive genes by representational difference analysis
Rivera, S. P., Saarikoski, S. T., Sun, W., & Hankinson, O. (2007) · Xenobiotica · doi:10.1080/00498250601169816 · Cited by 16
Self-citation
Bisphenol A is a carcinogen that induces lipid accumulation, peroxisome proliferator‑activated receptor‑γ expression and liver disease
Ismael, L. Q., Abdulhameed, A.-S. A. R., Keong, Y., Abdullah, M. N., Bahari, H., Jie, T., & Yin, K. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11671 · Cited by 15
A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach
Fekry, M. I., Xiao, Y., Berg, J. Z., & Guengerich, F. P. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089086 · Cited by 15
Characterization and expression of extrahepatic CYP2S1
Deb, S., & Bandiera, S. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902865586 · Cited by 15

Authors: Rivera, S. P., Saarikoski, S. T., & Hankinson, O.
Affiliations: University of California, Los Angeles (US)
Venue: Molecular Pharmacology
Publisher: Elsevier BV
Published: 2002-02
Volume: 61
Issue: 2
Pages: 255-259
ISSN: 0026-895X (ISSN-L)
DOI: 10.1016/s0026-895x(24)12856-8
OpenAlex: W2166454597
Cited by: 149
References: 12
Citations by year: 2025: 3 · 2024: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2017: 5 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 6
FWCI: 12.50
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Molecular Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (2 R01 CA28868-20, R01CA028868, R01 CA 28868)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords: CYP2S1, cytochrome P450, 2,3,7,8-tetrachlorodibenzo-p-dioxin, aryl hydrocarbon receptor, gene induction, lung epithelial cells, liver, representational difference analysis, cDNA cloning
MeSH terms: Amino Acid Sequence, Animals, Carcinogens, Cell Transformation, Neoplastic, Cytochrome P-450 Enzyme System, Dioxins, Enzyme Induction, Humans, Molecular Sequence Data, Oxygenases, RNA, Messenger, Transfection, Tumor Cells, Cultured, Gene Expression, Sequence Homology, Amino Acid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Identification of a Novel Dioxin-Inducible Cytochrome P450

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks